---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-099389"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2024-08-21T23:59:59+00:00"
generated_at: "2026-05-31T08:14:59.972696+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Axsome and Sandoz dismiss Sunosi patent litigation; Sandoz withdraws generic ANDA

## Summary
- Sandoz withdrew its ANDA for a generic equivalent of Sunosi (solriamfetol), leading to dismissal of patent litigation without prejudice.
- Litigation was pending in U.S. District Court for the District of New Jersey.
- Dismissal removes a potential near-term generic threat to Sunosi, Axsome's CNS product.

## SEC filing metadata
- accession: 0000950170-24-099389
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2024-08-21T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/0000950170-24-099389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/axsm-20240821.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-099389
- JSON: https://secwatch.observer/filing/0000950170-24-099389.json
- Plain text: https://secwatch.observer/filing/0000950170-24-099389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.